Hahn Stephen M. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hahn Stephen M. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Stephen M. Hahn is an American physician and oncologist who served as the 24th Commissioner of the U.S. Food and Drug Administration from December 2019 to December 2021. He has held prominent roles in medicine and academia, and, as of mid-2026, appears in SEC filings as a director of Sensei Biotherapeutics, Inc., reflecting his ongoing involvement with biotechnology leadership and governance.

Board memberships

• Sensei Biotherapeutics, Inc.

Awards & honors

• Former Commissioner of the U.S. Food and Drug Administration (Dec 2019 – Dec 2021)
• Renowned physician and oncologist with leadership experience in academia and biomedicine
• Board/director-level experience in biotechnology companies

Recent Transactions

Companies — Last 90 Days

• Faeth Therapeutics, Inc. (FTH) — 1 filings, last 2026-06-16

Frequently Asked Questions

Who is Hahn Stephen M.?

Stephen M. Hahn is an American physician and oncologist who served as the 24th Commissioner of the U.S. Food and Drug Administration from December 2019 to December 2021. He has held prominent roles in medicine and academia, and, as of mid-2026, appears in SEC filings as a director of Sensei Biotherapeutics, Inc., reflecting his ongoing involvement with biotechnology leadership …

How many SEC Form 4 filings has Hahn Stephen M. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Hahn Stephen M.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week